Publications by authors named "Huseyin Naci"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

2,643

Total Likes

154

Extended Reach

220,635

Social Features

47
P
Preferences for speed of access versus certainty of the survival benefit of new cancer drugs: a discrete choice experiment.
Robin Forrest, Mylene Lagarde, Ajay Aggarwal, Huseyin Naci

December 2024

Videos about Article: user user

2 2 30 2 15

View All Article and Social Media Activity
C
Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study.
Huseyin Naci, John P A Ioannidis

BMJ· October 2013

Videos about Article: user user

2 222 11 24 71

View All Article and Social Media Activity
P
Pediatric studies and labeling additions required by the U.S. FDA for novel drugs approved from 2011 to 2023: A retrospective cohort study.
Rylee McGonigle, Huseyin Naci, Maximilian Siebert, Michelle Ouvina, Alba Gutiérrez-Sacristán

PLoS Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reporting of Clinical Trial Uncertainties With New Cancer Drugs in Journal Publications and Clinical Guidelines.
Avi Cherla, Anita K Wagner, Olivier J Wouters, Steven Woloshin, Courtney Davis, Huseyin Naci

JAMA· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of evidence on overall survival benefits of cancer drugs included on the national reimbursement drug list of China, 2005-2022: an observational study.
Yichen Zhang, Huangqianyu Li, Jinyu Chen, Huseyin Naci, Anita K Wagner

BMJ Evid Based Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strength of evidence supporting cancer drug approvals in China between 2017 and 2021: a retrospective analysis.
Yichen Zhang, Dingyi Chen, Mengyuan Fu, Luwen Shi, Huseyin Naci

Lancet Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving productivity in the NHS.
Sally Gainsbury, Huseyin Naci

BMJ· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Cancer Drug Approvals: Less Than Half Of Important Clinical Trial Uncertainties Reported By The FDA To Clinicians, 2019-22.
Avi Cherla, Steven Woloshin, Anita K Wagner, Olivier J Wouters, Courtney Davis, Huseyin Naci

Health Aff (Millwood)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population health impact of NICE-recommended new drugs - Authors' reply.
Huseyin Naci, Peter Murphy, Beth Woods, James Lomas, Jinru Wei

Lancet· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population-health impact of new drugs recommended by the National Institute for Health and Care Excellence in England during 2000-20: a retrospective analysis.
Huseyin Naci, Peter Murphy, Beth Woods, James Lomas, Jinru Wei

Lancet· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of interim oncology treatments introduced for solid cancers during the COVID-19 pandemic in England: a retrospective evidence-based analysis.
Mark P Lythgoe, Alica-Joana Emhardt, Huseyin Naci, Jonathan Krell, Richard Sullivan

Lancet Reg Health Eur· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients deserve better information on new drugs.
Courtney Davis, Anita K Wagner, Barbara Mintzes, Henry Scowcroft, Steven Woloshin, Huseyin Naci

BMJ· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment methods for cervical intraepithelial neoplasia in England: A cost-effectiveness analysis.
Michela Tinelli, Antonios Athanasiou, Areti Angeliki Veroniki, Orestis Efthimiou, Ilkka Kalliala, Huseyin Naci

BJOG· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of transport, housing, and urban development interventions on older adults' mobility: A systematic review of experimental and quasi-experimental studies.
Thiago Hérick de Sá, Daniele Sudsataya, Andra Fry, Nazak Salehi, Aishwarya Katiki, Huseyin Naci

J Transp Health· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Effects in Randomized and Nonrandomized Studies of Pharmacological Interventions: A Meta-Analysis.
Maximilian Salcher-Konrad, Mary Nguyen, Jelena Savovic, Julian P T Higgins, Huseyin Naci

JAMA Netw Open· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health Technology Assessment in the US-A Word of Caution-Reply.
Olivier J Wouters, Huseyin Naci, Irene Papanicolas

JAMA Intern Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall survival benefits of cancer drugs initially approved by the US Food and Drug Administration on the basis of immature survival data: a retrospective analysis.
Huseyin Naci, Yichen Zhang, Steven Woloshin, Xiaodong Guan, Ziyue Xu

Lancet Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory histories of recently withdrawn ovarian cancer treatment indications of 3 PARP inhibitors in the US and Europe: lessons for the accelerated approval pathway.
Mahnum Shahzad, Huseyin Naci, Katharine M Esselen, Joseph A Dottino, Anita K Wagner

J Pharm Policy Pract· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence, diagnostic delay and economic burden of endometriosis and its impact on quality of life: results from an Eastern Mediterranean population.
Bethan Swift, Bahar Taneri, Christian M Becker, Hasan Basarir, Huseyin Naci

Eur J Public Health· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer drug indication approvals in China and the United States: a comparison of approval times and clinical benefit, 2001-2020.
Yuxuan Wei, Yichen Zhang, Ziyue Xu, Guoan Wang, Yue Zhou, Huseyin Naci

Lancet Reg Health West Pac· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Availability and Coverage of New Drugs in 6 High-Income Countries With Health Technology Assessment Bodies.
Olivier J Wouters, Huseyin Naci, Irene Papanicolas

JAMA Intern Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall survival benefits of cancer drugs in the WHO Model List of Essential Medicines, 2015-2021.
Yue Zhou, Huseyin Naci, Dingyi Chen, Lin Bai, Luwen Shi

BMJ Glob Health· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research evaluating the effectiveness of dementia interventions in low- and middle-income countries: A systematic mapping of 340 randomised controlled trials.
Maximilian Salcher-Konrad, Cheng Shi, Disha Patel, David McDaid, Claudia Iveth Astudillo-García, Huseyin Naci

Int J Geriatr Psychiatry· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marketing authorisation and pricing of FDA-approved cancer drugs in Brazil: a retrospective analysis.
Adriana M Ivama-Brummell, Fernanda L Marciniuk, Anita K Wagner, Claudia G S Osorio-de-Castro, Sabine Vogler, Huseyin Naci

Lancet Reg Health Am· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safeguarding NICE from patient groups' conflicts of interest.
Iva Parvanova, Arianna Gentilini, Jonathan Cushing, Huseyin Naci

BMJ· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis